Synthesis of 3-(arylamino) quinazoline-2,4(1H,3H)-dione derivatives via TBHP/I2: Molecular docking, MD simulation, DFT, and pharmacological evaluation as MTH1 inhibitors
PLOS One · 13.11.2025 · 20 (11) · e0335707
DOI: 10.1371/journal.pone.0335707 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 13.11.2025. Verfasst von Moeid Goudarzi Karim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, University of Guilan, Rasht, Iran. Hauptthemen laut MEDLINE: DNA Repair Enzymes, Phosphoric Monoester Hydrolases, Quinazolinones. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A series of novel derivatives of 3-(arylamino) quinazoline-2,4(1 H ,3 H )-dione were synthesized with moderate to good yields (20%−70%) using t -butyl hydroperoxide (TBHP) and iodine. Their efficacy against MutT homologue 1 (MTH1) was evaluated using in silico methods. Density functional theory (DFT) analysis, utilizing the B3LYP/6-311G (2df, p) basis set, indicated a promising reactivity profile for the synthesized compounds. The highest occupied molecular orbital (HOMO) regions associated with the phenylhydrazine group serve as sites for electron donation, functioning as electron-rich nucleophiles. Docking analysis with MTH1 enzymes revealed that all compounds exhibited docking scores ranging from −5.77 to −7.24, indicating favorable binding affinities. Among these, compound (3d) , with an energy of −7.24 kcal/mol, demonstrated the strongest binding affinity. Importantly, the Generalized Born and Surface Area Solvation (MM-GBSA) rescoring aligned with the docking data, reinforcing the reliability of the predicted binding modes and highlighting these compounds as promising MTH1 inhibitors. Molecular dynamics (MD) simulations indicated that Tyr7, Thr8, Lys23, and Trp117 exhibited a notably high interaction fraction, suggesting that these residues might be critical for the binding affinity of compound (3d) . The analysis of absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties indicated that all compounds possess a favorable pharmacological profile and comply with Lipinski’s Rule of Five (Ro5), as well as the Ghose, Veber, and Egan rules. Additionally, they are capable of human intestinal absorption (HIA) and exhibit no liver toxicity, whereas BAY-707 is anticipated to exhibit hepatotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Faculty of Science, University of Guilan, Rasht, Iran.
ORCID-Profile: Davood Gheidari
Zitieren
APA
Karim, M. G., Mehrdad, M., Gheidari, D., & Gheidari, N. Z. (2025). Synthesis of 3-(arylamino) quinazoline-2,4(1H,3H)-dione derivatives via TBHP/I2: Molecular docking, MD simulation, DFT, and pharmacological evaluation as MTH1 inhibitors. PLOS One, 20(11), e0335707. https://doi.org/10.1371/journal.pone.0335707
Vancouver
Karim MG, Mehrdad M, Gheidari D, Gheidari NZ. Synthesis of 3-(arylamino) quinazoline-2,4(1H,3H)-dione derivatives via TBHP/I2: Molecular docking, MD simulation, DFT, and pharmacological evaluation as MTH1 inhibitors. PLOS One. 2025;20(11):e0335707. doi:10.1371/journal.pone.0335707
BibTeX
@article{Karim2025,
author = {Karim, Moeid Goudarzi and Mehrdad, Morteza and Gheidari, Davood and Gheidari, Nazanin Zahra},
title = {Synthesis of 3-(arylamino) quinazoline-2,4(1H,3H)-dione derivatives via TBHP/I2: Molecular docking, MD simulation, DFT, and pharmacological evaluation as MTH1 inhibitors},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {11},
pages = {e0335707},
doi = {10.1371/journal.pone.0335707}
}
EUVIMED